Key Details
Price
$137.98Annual ROE
-26.52%Beta
1.66Events Calendar
Next earnings date:
Feb 06, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Feb 08, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
In the latest trading session, Cloudflare (NET) finished at $137.26, showing an increase of 0.6% compared to the day before.
San Diego, California, January 29, 2025 (GLOBE NEWSWIRE) -- California BanCorp ("we," "us," or the "Company") (NASDAQ: BCAL), which is the parent company of California Bank of Commerce, N.A. (the "Bank"), has released its financial results for the fourth quarter and the entire year of 2024.
Cloudflare (NET) experienced a significant rise in its stock price during the last trading session, with trading volume exceeding the usual amount. Recent changes in earnings estimates may lead to additional price growth in the near future.
Cloudflare's stock rose significantly during Tuesday's trading session. The company's share price increased by 10.7%, while the S&P 500 index gained 0.8% and the Nasdaq Composite index went up by 2%.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
Cloudflare (NET) has been getting a lot of interest from users on Zacks.com recently. As a result, it's important to understand the factors that could affect the stock's future.
![Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium](/static/news/2025/1/24/NET-perspective-therapeutics-continues-to-pursue-dose-escalation.webp "Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium")
The latest interim results from the ongoing Phase 1/2a study show that [212Pb]VMT-α-NET is safe and effective, with no serious side effects reported at the tested doses. In Cohort 2, three out of seven patients showed positive responses, while others maintained stable disease. These findings will be shared at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco.
Cloudflare (NET) finished the last trading session at $123.93, which represents a 0.68% increase from the previous day's closing price.
Cloudflare (NET) finished the latest trading session at $123.93, which represents a 0.68% increase from the previous day's closing price.
Cloudflare (NET) has reached its highest point in 52 weeks, but can investors expect further growth? We will examine the company's fundamentals for insights.
FAQ
- What is the primary business of Cloudflare?
- What is the ticker symbol for Cloudflare?
- Does Cloudflare pay dividends?
- What sector is Cloudflare in?
- What industry is Cloudflare in?
- What country is Cloudflare based in?
- When did Cloudflare go public?
- Is Cloudflare in the S&P 500?
- Is Cloudflare in the NASDAQ 100?
- Is Cloudflare in the Dow Jones?
- When was Cloudflare's last earnings report?
- When does Cloudflare report earnings?
- Should I buy Cloudflare stock now?